
Sascha Roth
patientFemale0.0Global Dominance: 0.00%
Sascha Roth is a 38-year-old cancer patient from Washington who was the first volunteer in a groundbreaking clinical trial involving the antibody dostarlimab, which has resulted in remarkable remission of her rectal cancer, showcasing the potential of this innovative treatment in eliminating tumors without surgery.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Sascha Roth was the first volunteer in the study and experienced rapid remission of her rectal cancer.
Un anticuerpo humanizado de ratón hace desaparecer el cáncer de 84 personas con una mutación genética | Salud y bienestarEl País·
Spain· 2025-05-09





